ROBERT ADLERSTEIN: Open Payments
NPI 1255085445 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,950 in 125 payments from 15 companies in 2025. Trend: 2023 $2,083 · 2024 $2,116 · 2025 $1,950
Food & beverage: $1,950
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 21 | $467 |
| ABBVIE INC. | 32 | $403 |
| Janssen Biotech, Inc. | 24 | $225 |
| E.R. Squibb & Sons, L.L.C. | 10 | $183 |
| ANI Pharmaceuticals, Inc. | 7 | $158 |
| Mallinckrodt Hospital Products Inc. | 14 | $156 |
| Amgen Inc. | 4 | $73 |
| Organon LLC | 3 | $65 |
| GlaxoSmithKline, LLC. | 3 | $58 |
| Novartis Pharmaceuticals Corporation | 2 | $34 |
Products named: Bimzelx, RINVOQ, TREMFYA, PURIFIED CORTROPHIN GEL, ACTHAR, ORENCIA, SKYRIZI, BENLYSTA.
Industry payments across NV — which companies pay providers there.
